EV/EBITDA

CVS’s current EV/EBITDA of 12.9x means that for every dollar of its earnings before interest, taxes, depreciation, and amortization, the market values the company (including its debt) at $12.90 — a measure of how cheap or expensive the stock is relative to its operating cash flow.

This sits slightly below the sector median of 13.4x, placing CVS at the 48th percentile among its sector peers, meaning roughly half are cheaper and half are more expensive. The metric has been stable over the last eight quarters, with a quarter-over-quarter decline of just 0.4% (year-over-year change is not available), indicating no major shift in valuation. Because the valuation is near the sector median and the trend is flat, there is neither a clear discount to exploit nor a premium that signals heightened risk — the stock appears fairly valued by this measure. This neutral stance does not directly support a CAUTIOUS verdict, but it also does not contradict it; the caution likely stems from other factors not captured by EV/EBITDA, such as debt levels or earnings stability.

Frequently Asked Questions

Closest Sector Peers